IMCR
Immunocore Holdings Ltd
30.30$
-1.8%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 623.8% | -156.4% | -224.1% | -427.3% | -70.3% | -394.9% | -201.1% | -529.1% | -34.1% | 1.2% | 10.5% | -2.7% | |
| 11.2% | 11.8% | 16.9% | 28.8% | 28.4% | 35.9% | 29.8% | 28.1% | 3.7% | 1.6% | 1.7% | 0.8% | |
| 1.0% | 12.9% | 10.2% | 22.6% | 2.8% | 11.9% | 27.1% | 180.8% | 22.8% | 13.0% | 13.8% | 12.7% | |
| – | – | -13.1% | -39.4% | -81.5% | 13.4% | 110.7% | 167.7% | 15.3% | – | – | – | |
| -18.1% | -14.8% | -21.2% | -115.3% | 285.7% | -39.3% | -95.6% | -81.2% | -16.8% | 2.3% | 18.2% | -2.3% | |
| 31.8% | 50.6% | 37.5% | 122.7% | 15.0% | 16.7% | 10.2% | 5.1% | 1.5% | 2.2% | 2.1% | 1.1% | |
| -89.1% | -45.4% | 178.7% | -67.4% | 245.3% | -16.1% | 1.6% | -4.7% | -1.5% | -2.2% | -143.2% | -4.1% | |
| – | – | – | – | 0.0% | – | 0.0% | 0.0% | 0.0% | 0.0% | – | – | |
| – | – | 112.5% | 128.2% | -17.1% | -15.7% | 110.0% | -11.7% | -2.2% | 0.0% | 142.1% | 0.0% | |
| 6.3% | 1,382.2% | 0.6% | 133.8% | 0.4% | 214.8% | 385.0% | 1,065.6% | 100.8% | 13.8% | 138.7% | 3.1% | |
| 797.1% | – | 815.7% | -361.0% | 175.5% | -196.4% | 185.1% | 534.0% | 56.4% | 16.1% | 5.3% | 3.0% | |
| 592.0% | -207.0% | -261.7% | -550.0% | -85.2% | -411.6% | -211.4% | -534.3% | -35.6% | -1.0% | 8.4% | -3.8% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.